Literature DB >> 21713591

Distinct plasma profile of polar neutral amino acids, leucine, and glutamate in children with Autism Spectrum Disorders.

Rabindra Tirouvanziam1, Tetyana V Obukhanych, Julie Laval, Pavel A Aronov, Robin Libove, Arpita Goswami Banerjee, Karen J Parker, Ruth O'Hara, Leonard A Herzenberg, Leonore A Herzenberg, Antonio Y Hardan.   

Abstract

The goal of this investigation was to examine plasma amino acid (AA) levels in children with Autism Spectrum Disorders (ASD, N = 27) and neuro-typically developing controls (N = 20). We observed reduced plasma levels of most polar neutral AA and leucine in children with ASD. This AA profile conferred significant post hoc power for discriminating children with ASD from healthy children. Furthermore, statistical correlations suggested the lack of a typical decrease of glutamate and aspartate with age, and a non-typical increase of isoleucine and lysine with age in the ASD group. Findings from this limited prospective study warrant further examination of plasma AA levels in larger cross-sectional and longitudinal cohorts to adequately assess for relationships with developmental and clinical features of ASD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21713591     DOI: 10.1007/s10803-011-1314-x

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN: 0162-3257


  31 in total

1.  Plasma amino acids profiles in children with autism: potential risk of nutritional deficiencies.

Authors:  Georgianne L Arnold; Susan L Hyman; Robert A Mooney; Russell S Kirby
Journal:  J Autism Dev Disord       Date:  2003-08

Review 2.  Immune-glutamatergic dysfunction as a central mechanism of the autism spectrum disorders.

Authors:  R L Blaylock; A Strunecka
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

3.  Brain volume in autism.

Authors:  A Y Hardan; N J Minshew; M Mallikarjuhn; M S Keshavan
Journal:  J Child Neurol       Date:  2001-06       Impact factor: 1.987

4.  Magnetic resonance imaging and head circumference study of brain size in autism: birth through age 2 years.

Authors:  Heather Cody Hazlett; Michele Poe; Guido Gerig; Rachel Gimpel Smith; James Provenzale; Allison Ross; John Gilmore; Joseph Piven
Journal:  Arch Gen Psychiatry       Date:  2005-12

5.  Plasma amino acid levels in children with autism and their families.

Authors:  Sarah Aldred; Kieran M Moore; Michael Fitzgerald; Rosemary H Waring
Journal:  J Autism Dev Disord       Date:  2003-02

6.  Age-specific distribution of plasma amino acid concentrations in a healthy pediatric population.

Authors:  N Lepage; N McDonald; L Dallaire; M Lambert
Journal:  Clin Chem       Date:  1997-12       Impact factor: 8.327

7.  Pyrosequencing study of fecal microflora of autistic and control children.

Authors:  Sydney M Finegold; Scot E Dowd; Viktoria Gontcharova; Chengxu Liu; Kathleen E Henley; Randall D Wolcott; Eunseog Youn; Paula H Summanen; Doreen Granpeesheh; Dennis Dixon; Minghsun Liu; Denise R Molitoris; John A Green
Journal:  Anaerobe       Date:  2010-07-09       Impact factor: 3.331

8.  Plasma tryptophan levels and tryptophan/neutral amino acid ratios in obsessive-compulsive patients with and without depression.

Authors:  L Bellodi; S Erzegovesi; L Bianchi; V Lucini; R Conca; A Lucca
Journal:  Psychiatry Res       Date:  1997-03-03       Impact factor: 3.222

9.  Amino acid cerebrospinal fluid/plasma ratios in children: influence of age, gender, and antiepileptic medication.

Authors:  Sabine Scholl-Bürgi; Edda Haberlandt; Peter Heinz-Erian; Florian Deisenhammer; Ursula Albrecht; Sara Baumgartner Sigl; Markus Rauchenzauner; Hanno Ulmer; Daniela Karall
Journal:  Pediatrics       Date:  2008-03-10       Impact factor: 7.124

10.  Application of the Phenomenex EZ:faasttrade mark amino acid analysis kit for rapid gas-chromatographic determination of concentrations of plasma tryptophan and its brain uptake competitors.

Authors:  A A-B Badawy; C J Morgan; J A Turner
Journal:  Amino Acids       Date:  2007-12-11       Impact factor: 3.520

View more
  23 in total

Review 1.  Are therapeutic diets an emerging additional choice in autism spectrum disorder management?

Authors:  M Gogou; G Kolios
Journal:  World J Pediatr       Date:  2018-05-30       Impact factor: 2.764

Review 2.  The role of glutamate and its receptors in autism and the use of glutamate receptor antagonists in treatment.

Authors:  Donald C Rojas
Journal:  J Neural Transm (Vienna)       Date:  2014-04-22       Impact factor: 3.575

3.  A randomized controlled pilot trial of oral N-acetylcysteine in children with autism.

Authors:  Antonio Y Hardan; Lawrence K Fung; Robin A Libove; Tetyana V Obukhanych; Surekha Nair; Leonore A Herzenberg; Thomas W Frazier; Rabindra Tirouvanziam
Journal:  Biol Psychiatry       Date:  2012-02-18       Impact factor: 13.382

Review 4.  Developing Medications Targeting Glutamatergic Dysfunction in Autism: Progress to Date.

Authors:  Lawrence K Fung; Antonio Y Hardan
Journal:  CNS Drugs       Date:  2015-06       Impact factor: 5.749

5.  The potential role of the antioxidant and detoxification properties of glutathione in autism spectrum disorders: a systematic review and meta-analysis.

Authors:  Penelope Ae Main; Manya T Angley; Catherine E O'Doherty; Philip Thomas; Michael Fenech
Journal:  Nutr Metab (Lond)       Date:  2012-04-24       Impact factor: 4.169

6.  Altered neurotransmitter metabolism in adolescents with high-functioning autism.

Authors:  Gerhard S Drenthen; Evelien M Barendse; Albert P Aldenkamp; Tamar M van Veenendaal; Nicolaas A J Puts; Richard A E Edden; Svitlana Zinger; Geert Thoonen; Marc P H Hendriks; Roy P C Kessels; Jacobus F A Jansen
Journal:  Psychiatry Res Neuroimaging       Date:  2016-09-20       Impact factor: 2.376

7.  Investigating Plasma Amino Acids for Differentiating Individuals with Autism Spectrum Disorder and Typically Developing Peers.

Authors:  Troy Vargason; Uwe Kruger; Deborah L McGuinness; James B Adams; Elizabeth Geis; Eva Gehn; Devon Coleman; Juergen Hahn
Journal:  Res Autism Spectr Disord       Date:  2018-03-30

8.  PLS-DA Model for the Evaluation of Attention Deficit and Hyperactivity Disorder in Children and Adolescents through Blood Serum FTIR Spectra.

Authors:  Gulce Ogruc Ildiz; Ahmet Karadag; Ersin Kaygisiz; Rui Fausto
Journal:  Molecules       Date:  2021-06-03       Impact factor: 4.411

9.  Gene-Environment Interactions in Developmental Neurotoxicity: a Case Study of Synergy between Chlorpyrifos and CHD8 Knockout in Human BrainSpheres.

Authors:  Sergio Modafferi; Xiali Zhong; Andre Kleensang; Yohei Murata; Francesca Fagiani; David Pamies; Helena T Hogberg; Vittorio Calabrese; Herbert Lachman; Thomas Hartung; Lena Smirnova
Journal:  Environ Health Perspect       Date:  2021-07-14       Impact factor: 9.031

Review 10.  Profiles of urine and blood metabolomics in autism spectrum disorders.

Authors:  Narueporn Likhitweerawong; Chanisa Thonusin; Nonglak Boonchooduang; Orawan Louthrenoo; Intawat Nookaew; Nipon Chattipakorn; Siriporn C Chattipakorn
Journal:  Metab Brain Dis       Date:  2021-08-02       Impact factor: 3.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.